Holen Sie sich die Stockscreener-App
4.07
17.44%
-0.86
Schlusskurs vom Vortag:
$4.93
Offen:
$4.63
24-Stunden-Volumen:
1.11M
Relative Volume:
3.10
Marktkapitalisierung:
$2.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.42M
KGV:
-0.1745
EPS:
-23.3189
Netto-Cashflow:
$-6.75M
1W Leistung:
-43.08%
1M Leistung:
-43.86%
6M Leistung:
-80.34%
1J Leistung:
-97.26%
1-Tages-Spanne:
$3.9411
$4.6944
1-Wochen-Bereich:
$3.9411
$7.77
52-Wochen-Spanne:
$3.9411
$156.60
Silexion Therapeutics Corp Stock (SLXN) Company Profile
Firmenname
Silexion Therapeutics Corp
Sektor
Branche
Telefon
972-8-6286005
Adresse
12 ABBA HILLEL ROAD, RAMAT GAN
Vergleichen Sie SLXN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLXN
Silexion Therapeutics Corp
|
4.07 | 3.28M | 0 | -16.42M | -6.75M | -23.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Silexion Therapeutics Corp Aktie (SLXN) Neueste Nachrichten
Silexion Therapeutics announces pricing of $6M public offering - MSN
Silexion Therapeutics Shares Surge On Positive Preclinical Pancreatic Cancer Data - Benzinga
Silexion Therapeutics Reveals Positive Preclinical Data for SIL204 - TipRanks
Silexion Therapeutics announces pricing of $6.0 million public offering - MarketScreener
Silexion Therapeutics prices 1.5M shares at $4.00 in public offering - TipRanks
Why Is Silexion Therapeutics Stock (SLXN) Up 190% Today? - TipRanks
Silexion Therapeutics Announces Pricing of $6.0 Million Public Offering - GlobeNewswire
$6M Capital Raise: Clinical-Stage RNAi Cancer Biotech Silexion Prices Share & Warrant Offering at $4.00 - Stock Titan
Silexion shares skyrocket 400% after encouraging pancreatic cancer drug results - MSN
Silexion Therapeutics announces preclinical data on SIL204 - TipRanks
Silexion stock soars 400% after positive pancreatic cancer drug data By Investing.com - Investing.com Australia
Silexion reports positive preclinical data demonstrating SIL204's reach - MarketScreener
Silexion stock soars 400% after positive pancreatic cancer drug data - Investing.com
Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204’s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration - The Manila Times
Breakthrough: Cancer Drug Reaches All Major Metastatic SitesSilexion's SIL204 Shows Promise for Fatal Disease - Stock Titan
Can Silexion Therapeutics Corp keep up with sector leadersJuly 2025 Selloffs & Weekly High Return Opportunities - Lancaster City Council
What’s the profit margin of Silexion Therapeutics CorpJuly 2025 Pullbacks & Low Risk Entry Point Guides - Lancaster City Council
Watch for Trend Continuation in Silexion Therapeutics Corp Next WeekJuly 2025 Earnings & Reliable Volume Spike Trade Alerts - beatles.ru
RSI Crosses Above 30 for Silexion Therapeutics Corp Equity Warrant — Reversal in SightChart Signals & Precise Buy Zone Tips - beatles.ru
AI Trend Models Suggest Bounce for Silexion Therapeutics Corp Equity WarrantSell Signal & Low Risk Investment Opportunities - beatles.ru
Is Silexion Therapeutics Corp Equity Warrant subject to activist investor interestJuly 2025 Retail & Smart Investment Allocation Tips - beatles.ru
Technical Bounce Expected in Silexion Therapeutics Corp Next WeekPortfolio Gains Summary & Consistent Income Trade Recommendations - beatles.ru
Live Chart Scan Detects Wedge Pattern in Silexion Therapeutics Corp2025 Geopolitical Influence & Stepwise Entry and Exit Trade Signals - beatles.ru
Is Silexion Therapeutics Corp Equity Warrant meeting your algorithmic filter criteriaWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Why Silexion Therapeutics Corp Equity Warrant is moving todayJuly 2025 Volume & Trade Opportunity Analysis Reports - Newser
Why Silexion Therapeutics Corp is moving today2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
What’s next for Silexion Therapeutics Corp Equity Warrant stock priceJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - Newser
Applying Wyckoff theory to Silexion Therapeutics Corp stock2025 Price Targets & High Return Stock Watch Alerts - Newser
Signal Recap: Is Silexion Therapeutics Corp Equity Warrant’s growth already priced inInflation Watch & Weekly High Return Forecasts - خودرو بانک
Can Silexion Therapeutics Corp Equity Warrant benefit from deglobalization2025 Volume Leaders & Fast Exit and Entry Strategy Plans - خودرو بانک
What is Silexion Therapeutics Corp Equity Warrant’s book value per shareWeekly Trade Summary & Capital Efficiency Focused Strategies - خودرو بانک
Automated trading signals detected on Silexion Therapeutics Corp Equity WarrantIPO Watch & Expert Curated Trade Ideas - Newser
Earnings Report: Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soon2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - خودرو بانک
Is Silexion Therapeutics Corp Equity Warrant’s growth already priced in2025 Market Outlook & Accurate Buy Signal Notifications - خودرو بانک
What recovery options are there for Silexion Therapeutics Corp Equity Warrant2025 Breakouts & Breakdowns & High Conviction Trade Alerts - Newser
Silexion selects CRO partner for upcoming KRAS cancer therapy trials By Investing.com - Investing.com Canada
Can Silexion Therapeutics Corp Equity Warrant disrupt its industry2025 Top Decliners & Fast Moving Trade Plans - خودرو بانک
What high frequency data says about Silexion Therapeutics CorpAnalyst Downgrade & Community Consensus Stock Picks - Newser
Will Silexion Therapeutics Corp Equity Warrant see short term momentumGDP Growth & Community Verified Trade Signals - Newser
Silexion Therapeutics Corp Equity Warrant stock prediction for this week2025 EndofYear Setup & Consistent Income Trade Recommendations - Newser
Backtesting results for Silexion Therapeutics Corp trading strategies2025 Price Action Summary & Risk Controlled Daily Trade Plans - Newser
Is it time to cut losses on Silexion Therapeutics Corp Equity Warrant2025 Biggest Moves & Community Consensus Picks - Newser
Silexion Therapeutics Announces Selection of Contract - GlobeNewswire
Chart overlay techniques for tracking Silexion Therapeutics CorpWeekly Trade Recap & Weekly Breakout Watchlists - Newser
silexion therapeutics corp equity warrant stock prediction for this weekTrade Analysis Report & Low Drawdown Investment Strategies - Newser
Detecting support and resistance levels for Silexion Therapeutics CorpJuly 2025 Market Mood & Precise Buy Zone Tips - Newser
Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soonJuly 2025 PostEarnings & Stepwise Trade Signal Guides - خودرو بانک
Silexion Therapeutics Partners with AMS for Clinical Trials - MSN
Silexion Therapeutics CorpPhase 2/3 trials to start in first half of 2026 - MarketScreener
Silexion Therapeutics selects AMS as CRO for SIL204 Phase 2/3 trials - TipRanks
Silexion selects CRO partner for upcoming KRAS cancer therapy trials - Investing.com
Finanzdaten der Silexion Therapeutics Corp-Aktie (SLXN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):